Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for evaluation of genetically confirmed Familial Adenomatous Polyposis (FAP). Reports [number/frequency] of bowel movements per day, presence of hematochezia, or abdominal discomfort. Family history positive for FAP/CRC in [relative]. Current surveillance status: [colonoscopy/sigmoidoscopy] performed on [date] showing [number] adenomatous polyps.
Clinical Examination Findings
Abdomen: Soft, non-distended, non-tender to palpation. No palpable masses or organomegaly. Digital Rectal Exam (DRE): [No palpable rectal polyps / Multiple rectal polyps noted]. Skin: [Absence/Presence] of epidermoid cysts, lipomas, or fibromas (Gardner syndrome stigmata). Ocular: [Absence/Presence] of CHRPE (Congenital Hypertrophy of the Retinal Pigment Epithelium).
Treatment Protocol
Surgical management plan: [Total Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA) / Total Colectomy with Ileorectal Anastomosis (IRA)]. Prophylactic surgery indicated due to high risk of malignant transformation. Post-operative surveillance: Annual pouchoscopy or proctoscopy for rectal stump monitoring. Chemoprevention: Consider NSAIDs/COX-2 inhibitors as adjuvant therapy.
1. Comprehensive Executive Overview: Understanding FAP
Familial Adenomatous Polyposis (FAP), classified under ICD-10 code D12.6, is a severe, autosomal dominant hereditary disorder characterized by the development of hundreds to thousands of adenomatous polyps in the colon and rectum. If left untreated, the cumulative lifetime risk of developing colorectal cancer (CRC) in patients with classic FAP approaches 100%, typically occurring at a mean age of 39 to 45 years.
FAP represents approximately 1% of all colorectal cancer cases. Because it is a systemic genetic condition, it is not merely a localized colonic disease; it is a clinical marker for a broader predisposition to extracolonic manifestations, including duodenal adenomas, desmoid tumors, osteomas, and dental abnormalities. Early detection via genetic counseling and rigorous endoscopic surveillance is the clinical standard of care to mitigate mortality.
2. Pathophysiology, Etiology, and Risk Factors
The Genetic Basis
FAP is caused by germline mutations in the Adenomatous Polyposis Coli (APC) gene, located on the long arm of chromosome 5 (5q21-q22). The APC protein is a tumor suppressor that plays a pivotal role in the Wnt signaling pathway.
- Wnt Signaling Pathway: Under normal conditions, the APC protein facilitates the degradation of beta-catenin. In FAP, the mutation results in a truncated or non-functional APC protein.
- Consequence: Beta-catenin accumulates in the cytoplasm and translocates to the nucleus, where it acts as a transcription factor for oncogenes like c-MYC and cyclin D1, leading to uncontrolled epithelial cell proliferation and adenoma formation.
Inheritance Patterns
FAP follows an autosomal dominant inheritance pattern. Each offspring of an affected individual has a 50% probability of inheriting the germline mutation. However, approximately 25% of patients present as de novo cases, meaning they possess no family history but have acquired a spontaneous mutation.
| Feature | Clinical Significance |
|---|---|
| Gene Involved | APC (Adenomatous Polyposis Coli) |
| Chromosomal Location | 5q21-q22 |
| Penetrance | Nearly 100% by age 40 |
| Inheritance | Autosomal Dominant |
3. Signs, Symptoms, and Clinical Presentation
The clinical presentation of FAP is often insidious. Many patients are asymptomatic during the early stages of polyp development.
Common Symptoms
- Hematochezia: Rectal bleeding or blood mixed with stool.
- Altered Bowel Habits: Unexplained diarrhea or constipation.
- Abdominal Pain: Often associated with late-stage obstruction or desmoid tumor formation.
- Anemia: Iron deficiency secondary to chronic occult bleeding.
Extracolonic Manifestations (Gardner Syndrome)
When FAP is associated with extracolonic manifestations, it is often historically referred to as "Gardner Syndrome." These include:
1. Osteomas: Commonly in the skull or mandible.
2. Soft Tissue Tumors: Epidermoid cysts, fibromas, and desmoid tumors.
3. Dental Abnormalities: Supernumerary or impacted teeth.
4. Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE): A highly specific diagnostic marker visible on ophthalmoscopy.
4. Standard Diagnostic Evaluation & Workup
The diagnostic workup for FAP requires a multidisciplinary approach involving gastroenterologists, geneticists, and surgeons.
Genetic Testing
Genetic testing is the gold standard for diagnosing FAP in asymptomatic family members. If the specific APC mutation has been identified in the index case (proband), predictive genetic testing can be performed on at-risk relatives.
Endoscopic Surveillance
- Flexible Sigmoidoscopy/Colonoscopy: The primary tool for diagnosis. The presence of >100 adenomatous polyps is generally diagnostic for classic FAP.
- Upper Endoscopy (EGD): Essential for assessing the duodenum and periampullary region for adenomas (Spigelman staging).
Diagnostic Criteria Summary
- Clinical: >100 colorectal adenomas.
- Genetic: Identification of a pathogenic germline mutation in the APC gene.
- Family History: Known FAP diagnosis in a first-degree relative.
5. Therapeutic Interventions
Management of FAP is primarily surgical, as chemoprevention alone is insufficient to prevent the inevitable progression to malignancy.
Surgical Management
The timing of surgery is dictated by the number, size, and histological grade of the polyps.
* Total Proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA): The standard of care for patients with extensive rectal disease. It removes all colonic and rectal mucosa, eliminating the risk of CRC.
* Total Colectomy with Ileorectal Anastomosis (IRA): Reserved for patients with a sparse rectal polyp burden. It requires lifelong, rigorous surveillance of the rectal stump, as the risk of rectal cancer remains significant.
Pharmacotherapy
- NSAIDs (Celecoxib/Sulindac): These agents have been shown to reduce the number and size of adenomas in the colon and rectum. They are currently used as an adjunct to surgery or for patients with a small rectal remnant, but they do not eliminate the need for surgical intervention.
Lifestyle and Long-term Prognosis
Patients must adhere to a strict surveillance schedule post-surgery. Even with an IPAA, there remains a small risk of adenoma development in the pouch (pouchitis or pouch adenomas). Annual screening for extracolonic cancers (thyroid, small bowel, and pancreas) is mandatory.
6. FAQ: Frequently Asked Questions
1. Is FAP considered a form of cancer?
No, FAP is a genetic pre-cancerous condition. However, if left untreated, it has a near 100% progression rate to colorectal cancer.
2. At what age should screening begin?
For children of parents with FAP, genetic testing should be offered at age 10-12. If the child is positive for the mutation, annual colonoscopy/sigmoidoscopy should begin.
3. Can I have FAP without a family history?
Yes. Approximately 25% of FAP cases are "sporadic" or de novo mutations, meaning neither parent carries the gene.
4. What is the difference between classic and attenuated FAP (AFAP)?
Classic FAP involves hundreds to thousands of polyps appearing in the teens. Attenuated FAP (AFAP) involves fewer polyps (usually <100) and a later onset of cancer.
5. What is a Desmoid tumor?
Desmoid tumors are non-metastasizing but locally aggressive fibrous tumors. They are a common, difficult-to-treat manifestation in FAP patients, particularly following abdominal surgery.
6. Does removing the colon cure FAP?
Surgery eliminates the risk of colorectal cancer. However, it does not cure the underlying genetic defect, so patients remain at risk for extracolonic manifestations.
7. Are there dietary changes that help with FAP?
While no diet prevents the genetic progression of FAP, a high-fiber, low-fat diet is recommended for general colon health, though it does not replace the need for surgery.
8. What is the Spigelman score?
It is a staging system used to classify the severity of duodenal polyposis in FAP patients, which helps determine the frequency of follow-up endoscopies.
9. Can women with FAP have children?
Yes. However, genetic counseling is highly recommended due to the 50% chance of passing the condition to offspring.
10. What is the role of the APC gene?
The APC gene acts as a "brake" on cell division. When mutated, the brake is removed, allowing cells to multiply uncontrollably, leading to polyp formation.
Disclaimer: This guide is intended for informational purposes for patients and does not replace professional medical advice. Always consult with a colorectal surgeon or genetic counselor regarding individual diagnostic and treatment plans.